Summary
S&P Global Ratings analysts held a live, interactive webinar on Wednesday, September 23, 2026, where they discussed the key credit factors underpinning our preliminary rating of Sun Pharmaceutical Industries Ltd.
Key discussion points included:
- The key drivers behind Sun Pharmaceutical's issuer credit rating
- Our credit view on the acquiree, Organon & Co.
- Financial impact and deleveraging path post Organon & Co. acquisition
- Key watchpoints for the ratings
Speakers:
Arthur Wong, Managing Director, Healthcare Sector Lead, Corporate Ratings
Shruti Zatakia, Associate Director, Corporate Ratings
Chi Yang Leong, Senior Analyst, Corporate Ratings
Moderator:
Shawn Park, Director, Corporate Ratings
This webinar replay is free of charge.
Questions?
Please contact us if you need more information or have trouble accessing the webinar.